$ALXO
ALX ONCOLOGY HOLDINGS INC

2020 Q2 Form 10-Q Financial Statement

#000156459020041556 Filed on August 27, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $527.0K $1.295M
YoY Change -59.31%
Cost Of Revenue $480.0K $1.180M
YoY Change -59.32%
Gross Profit $50.00K $120.0K
YoY Change -58.33%
Gross Profit Margin 9.49% 9.27%
Selling, General & Admin $3.170M $680.0K
YoY Change 366.18%
% of Gross Profit 6340.0% 566.67%
Research & Development $7.663M $3.628M
YoY Change 111.22%
% of Gross Profit 15326.0% 3023.33%
Depreciation & Amortization $80.00K $110.0K
YoY Change -27.27%
% of Gross Profit 160.0% 91.67%
Operating Expenses $11.31M $5.484M
YoY Change 106.31%
Operating Profit -$10.79M -$4.189M
YoY Change 157.51%
Interest Expense -$219.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$310.0K $0.00
YoY Change
Pretax Income -$11.31M -$4.189M
YoY Change 170.02%
Income Tax $20.00K $8.000K
% Of Pretax Income
Net Earnings -$11.33M -$4.197M
YoY Change 169.98%
Net Earnings / Revenue -2150.09% -324.09%
Basic Earnings Per Share
Diluted Earnings Per Share -$306.5K -$121.0K
COMMON SHARES
Basic Shares Outstanding 3.165M 3.087M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $98.10M
YoY Change
Cash & Equivalents $98.10M $9.088M
Short-Term Investments
Other Short-Term Assets $2.000M
YoY Change
Inventory
Prepaid Expenses
Receivables $500.0K
Other Receivables $0.00
Total Short-Term Assets $100.7M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.411M
YoY Change
Total Long-Term Assets $2.412M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $100.7M
Total Long-Term Assets $2.412M
Total Assets $103.1M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.865M
YoY Change
Accrued Expenses $3.500M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $1.714M
YoY Change
Total Short-Term Liabilities $7.719M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $3.928M
YoY Change
Other Long-Term Liabilities $800.0K
YoY Change
Total Long-Term Liabilities $3.928M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $7.719M
Total Long-Term Liabilities $3.928M
Total Liabilities $11.65M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$89.57M
YoY Change
Common Stock $5.169M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$84.40M -$60.04M
YoY Change
Total Liabilities & Shareholders Equity $103.1M
YoY Change

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$11.33M -$4.197M
YoY Change 169.98%
Depreciation, Depletion And Amortization $80.00K $110.0K
YoY Change -27.27%
Cash From Operating Activities -$6.170M -$4.330M
YoY Change 42.49%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$300.0K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$300.0K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -770.0K 9.430M
YoY Change -108.17%
NET CHANGE
Cash From Operating Activities -6.170M -4.330M
Cash From Investing Activities 0.000 -300.0K
Cash From Financing Activities -770.0K 9.430M
Net Change In Cash -6.940M 4.800M
YoY Change -244.58%
FREE CASH FLOW
Cash From Operating Activities -$6.170M -$4.330M
Capital Expenditures $0.00 -$300.0K
Free Cash Flow -$6.170M -$4.030M
YoY Change 53.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
641000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2411000
CY2020Q2 us-gaap Assets
Assets
103112000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1865000
CY2019Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1236000
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1714000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7719000
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3928000
CY2019Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
135000
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
3000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5166000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2140000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-89567000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-72782000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-84398000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4984000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5421000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-70639000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
103112000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10676000
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3628000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11491000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7361000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3172000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1519618271
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1519618271
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3166946
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3166946
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3166946
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3166946
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
527000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1295000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1182000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2327000
CY2020Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
alxo:RelatedPartyMember
CY2019Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
alxo:RelatedPartyMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
alxo:RelatedPartyMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
alxo:RelatedPartyMember
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7663000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
679000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4645000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1267000
CY2020Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
479000
CY2019Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
1177000
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
1075000
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
2115000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
11314000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
5484000
us-gaap Operating Expenses
OperatingExpenses
17211000
us-gaap Operating Expenses
OperatingExpenses
10743000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-10787000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4189000
us-gaap Operating Income Loss
OperatingIncomeLoss
-16029000
us-gaap Operating Income Loss
OperatingIncomeLoss
-8416000
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-219000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-434000
CY2020Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
305000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
298000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
2000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11311000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4189000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16761000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8418000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-11331000
us-gaap Net Income Loss
NetIncomeLoss
-16785000
us-gaap Net Income Loss
NetIncomeLoss
-8435000
CY2020Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2641000
CY2019Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
981000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
4624000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1886000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13972000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5178000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21409000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10321000
CY2020Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-4.41
CY2019Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-1.68
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-6.78
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-3.39
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3164707
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3087355
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3157387
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3047924
CY2019Q1 alxo Stock Issued During Period Value Vesting Of Early Exercised Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions
21000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
76000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-4238000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-55919000
CY2019Q2 alxo Stock Issued During Period Value Vesting Of Early Exercised Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions
20000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-60036000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-5454000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-75926000
CY2020Q2 alxo Stock Issued During Period Value Vesting Of Early Exercised Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions
6000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2853000
us-gaap Profit Loss
ProfitLoss
-16785000
us-gaap Profit Loss
ProfitLoss
-8435000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
192000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
206000
us-gaap Share Based Compensation
ShareBasedCompensation
3004000
us-gaap Share Based Compensation
ShareBasedCompensation
136000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
221000
alxo Changes In Fair Value Of Compound Derivative Liability And Warrants
ChangesInFairValueOfCompoundDerivativeLiabilityAndWarrants
408000
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-9000
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
418000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1137000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-327000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2003000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
476000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1100000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-483000
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-135000
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
2000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15126000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8189000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
415000
alxo Proceeds From Issuance Of Related Parties Convertible Preferred Stock
ProceedsFromIssuanceOfRelatedPartiesConvertiblePreferredStock
68452000
alxo Proceeds From Issuance Of Related Parties Convertible Preferred Stock
ProceedsFromIssuanceOfRelatedPartiesConvertiblePreferredStock
6829000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
36228000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
2601000
alxo Payment For Deferred Offering Costs
PaymentForDeferredOfferingCosts
458000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
104222000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9430000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
89086000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
826000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9017000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8262000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98103000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9088000
us-gaap Interest Paid Net
InterestPaidNet
188000
alxo Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
22000
alxo Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
41000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1953000
us-gaap Interest Expense Debt
InterestExpenseDebt
400000
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
214000
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3743000
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3007000
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On July 8, 2020, the Company’s board of directors approved an amendment to the Company’s certificate of incorporation to effect a 1-for-6.5806 reverse split of its common stock and convertible preferred stock.
CY2020Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
2411000
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2019Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
129000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2309000
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
92000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1449000
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
100000
CY2020Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2019Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2019Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2019Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
100000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
200000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
200000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
122000
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
671000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
924000
CY2020Q2 alxo Accrued Clinical And Non Clinical Costs Current
AccruedClinicalAndNonClinicalCostsCurrent
800000
CY2020Q2 alxo Accrued Contract Manufacturing Current
AccruedContractManufacturingCurrent
149000
CY2019Q4 alxo Accrued Contract Manufacturing Current
AccruedContractManufacturingCurrent
53000
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
301000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
137000
CY2020Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
358000
CY2020Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
200000
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
4624000
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
1886000
CY2020Q2 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
4511000
CY2020Q2 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
1563000
CY2020Q2 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
298000
CY2020Q2 us-gaap Purchase Obligation
PurchaseObligation
6372000
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
6964000
CY2020Q2 alxo Long Term Debt Maturities Repayments Of Debt Including Interest And Principal
LongTermDebtMaturitiesRepaymentsOfDebtIncludingInterestAndPrincipal
6964000
CY2020Q2 alxo Long Term Debt Maturities Repayments Of Interest
LongTermDebtMaturitiesRepaymentsOfInterest
604000
CY2020Q2 alxo Long Term Debt Maturities Repayments Of Final Payment
LongTermDebtMaturitiesRepaymentsOfFinalPayment
360000
CY2020Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
6000000
CY2020Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
25417750
CY2019Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
12156391
CY2020Q2 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
21461756
CY2020Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
200000
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
200000
us-gaap Operating Lease Expense
OperatingLeaseExpense
400000
us-gaap Operating Lease Expense
OperatingLeaseExpense
400000
CY2020Q2 alxo Temporary Equity Shares Issued And Outstanding
TemporaryEquitySharesIssuedAndOutstanding
21369774
CY2020Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
175043000
CY2020Q2 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
193220000
CY2019Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
11567003
CY2019Q4 alxo Temporary Equity Shares Issued And Outstanding
TemporaryEquitySharesIssuedAndOutstanding
10313808
CY2019Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
70363000
CY2019Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
83585000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2853000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
60000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3004000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
136000
CY2020Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
2641000
CY2019Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
981000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3164707
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3087355
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3157387
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3047924
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.41
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.68
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1657000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-6.78
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.39
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25309789
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11310565
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
273000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
560000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
577000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
247000

Files In Submission

Name View Source Status
0001564590-20-041556-index-headers.html Edgar Link pending
0001564590-20-041556-index.html Edgar Link pending
0001564590-20-041556.txt Edgar Link pending
0001564590-20-041556-xbrl.zip Edgar Link pending
alxo-10q_20200630.htm Edgar Link pending
alxo-20200630.xml Edgar Link completed
alxo-20200630.xsd Edgar Link pending
alxo-20200630_cal.xml Edgar Link unprocessable
alxo-20200630_def.xml Edgar Link unprocessable
alxo-20200630_lab.xml Edgar Link unprocessable
alxo-20200630_pre.xml Edgar Link unprocessable
alxo-ex311_11.htm Edgar Link pending
alxo-ex312_10.htm Edgar Link pending
alxo-ex321_8.htm Edgar Link pending
alxo-ex322_9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending